Staar Surgical Co. (STAA) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026
Summary
Staar Surgical’s revenue went from $82M in fiscal 2016 to $239M in fiscal 2025, growth of about 12.6% a year.
Net income in fiscal 2025 was -$80M, a net margin of -33.6%; the best year in this period was 2022 with $40M.
Over the twelve months to October 2, 2026, revenue was $328M and net income $530000.
Free cash flow was -$40M in fiscal 2025 and positive in 6 of the 10 years shown.
The diluted share count rose 23% over the period (dilution).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $328M | $239M | $314M | $322M | $239M | $230M | $163M | $150M | $124M | $91M | $82M |
| Gross profit | $241M | $182M | $240M | $253M | $223M | $179M | $118M | $112M | $92M | $64M | $58M |
| Operating income | $701000 | -$92M | -$13M | $28M | $44M | $33M | $7M | $12M | $7M | -$4M | -$13M |
| Net income | $530000 | -$80M | -$20M | $21M | $40M | $28M | $6M | $14M | $5M | -$2M | -$12M |
| EPS (diluted) | $0.01 | $-1.62 | $-0.41 | $0.43 | $0.80 | $0.56 | $0.12 | $0.30 | $0.11 | $-0.05 | $-0.30 |
| R&D | $40M | $40M | $45M | $40M | $36M | $34M | $32M | $25M | $22M | $20M | $21M |
| Revenue growth | — | −23.7% | −2.6% | +34.6% | +3.9% | +41.0% | +8.8% | +21.2% | +36.8% | +9.9% | +6.9% |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $21M | -$34M | $16M | $15M | $36M | $44M | $21M | $26M | $13M | $3M | $1M |
| Capital spending | -$4M | -$6M | -$23M | -$18M | -$18M | -$14M | -$8M | -$10M | -$2M | -$1M | -$3M |
| Free cash flow | $18M | -$40M | -$8M | -$4M | $18M | $30M | $13M | $16M | $11M | $2M | -$2M |
| Dividends paid | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Buybacks | — | $6M | — | — | — | — | — | — | — | — | — |
| Stock-based pay | $26M | $31M | $27M | $24M | $20M | $15M | $12M | $11M | $7M | $3M | $9M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $188M | $230M | $221M | $212M | $200M | $152M | $120M | $104M | $19M | $14M |
| Debt | — | $38M | $39M | $36M | $31M | $32M | $10M | $9M | $4M | $4M | $4M |
| Equity | — | $344M | $397M | $386M | $336M | $262M | $197M | $160M | $132M | $43M | $38M |
| Total assets | — | $452M | $510M | $489M | $419M | $346M | $257M | $208M | $167M | $68M | $65M |
| Shares (diluted) | 51M | 50M | 49M | 49M | 49M | 49M | 48M | 47M | 45M | 41M | 40M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 73.6% | 76.2% | 76.3% | 78.4% | 93.3% | 77.5% | 72.4% | 74.5% | 73.8% | 70.9% | 70.8% |
| Operating margin | 0.2% | -38.3% | -4.0% | 8.7% | 18.3% | 14.5% | 4.1% | 7.9% | 5.3% | -4.0% | -15.3% |
| Net margin | 0.2% | -33.6% | -6.4% | 6.6% | 16.6% | 11.9% | 3.6% | 9.3% | 4.0% | -2.4% | -14.7% |
| FCF margin | 5.4% | -16.7% | -2.4% | -1.1% | 7.3% | 13.2% | 7.7% | 10.4% | 8.5% | 2.0% | -2.6% |
| ROIC | — | -23.4% | -2.3% | 4.2% | 10.4% | 10.0% | 2.3% | 5.6% | 3.6% | -7.1% | -29.2% |
| ROE | — | -23.4% | -5.1% | 5.5% | 11.8% | 10.5% | 3.0% | 8.8% | 3.8% | -5.0% | -32.0% |
Frequently asked questions
What is Staar Surgical’s annual revenue?
$239M in fiscal 2025 and $328M over the twelve months to October 2, 2026.
How much profit does Staar Surgical make?
Net income was -$80M in fiscal 2025 (net margin -33.6%).
Is Staar Surgical’s revenue growing?
No: revenue fell 23.7% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.